High mobility group box 3 pseudogene 4 (HMGB3P4)

High mobility group box 3 pseudogene 4 (HMGB3P4) is a **pseudogene**, meaning it is a segment of DNA similar to a functional gene (high mobility group box 3, HMGB3) but is generally regarded as nonfunctional—unable to encode a functional protein product[2][3]. Pseudogenes may sometimes be transcribed into RNA, but typically do not produce active proteins, and their biological roles, if any, are usually regulatory or none at all[2][1]. HMGB3P4 is cataloged as a pseudogene in major genetic databases, and there is no evidence in the current literature that it acts as a functional receptor, enzyme, transporter, or any other established type of **therapeutic target**[3]. There is also no documented association of interacting drugs, mechanisms of action, biomarker use, or disease relevance for this specific pseudogene[3]. **Note**: - This entry is "incorrect" as a conventional target, because pseudogenes such as HMGB3P4 are not regarded as therapeutic targets, do not encode proteins, and are not categorized as receptors, enzymes, or signaling molecules relevant for pharmacological intervention[2][3]. - The main, scientifically accurate name should remain as "high mobility group box 3 pseudogene 4" with the abbreviation HMGB3P4. - No alternative aliases or actionable biology is documented for this gene. - No relevance for tangible drug development, safety concerns, or use as a biomarker is reported.

Other names

HMGB3P4